<DOC>
	<DOC>NCT01365091</DOC>
	<brief_summary>To demonstrate the bioequivalence of saxagliptin and metformin in a saxagliptin, 5-mg/metformin extended-release (XR), 500-mg, fixed-dose combination (FDC) tablet with saxagliptin, 5-mg and metformin, 500-mg XR tablets administered together in both the fasted and fed states. In addition, to demonstrate the bioequivalence of saxagliptin and metformin in a saxagliptin, 5-mg/metformin XR, 1000-mg, FDC tablet with saxagliptin, 5-mg and metformin, 1000-mg XR tablets administered together in both the fasted and fed states.</brief_summary>
	<brief_title>Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Key Healthy men and women women of childbearing potential who are using acceptable method of contraception Women who are not pregnant or nursing Body Mass Index (BMI) of 18 to 29.9 kg/m^2, inclusive. BMI=weight(kg)/height(m)^2. Key Any significant acute or chronic medical illness. History of gastrointestinal (GI) disease Major surgery within 4 weeks of study drug administration Any GI surgery that could impact study drug absorption Donation of blood or plasma to a blood bank or in a clinical study (except a screening visit) within the 6 months of study drug administration. Blood transfusion within 3 months of study drug administration for women and within 2 months for men Inability to be venipunctured and/or tolerate venous access Current smoker or recent (within 1 month) history of regular tobacco use Recent (within 6 months of study drug administration) drug or alcohol abuse Participation in a bioequivalence study within the last 6 months of study drug administration Estimated creatinine clearance of &lt;80 mL/min using CockcroftGault formula History of allergy to drug class or related compounds History of allergy to metformin or other similar acting agents History of any significant drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>